Release Date: 07/10/21 11:04 Summary: Qube Response to ACCC Inquiry into NAT acquisition Price Sensitive: No Download Document 274.09KB Download
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution